Northern Trust Corp raised its stake in shares of Psychemedics Corp. (NASDAQ:PMD) by 96.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 38,227 shares of the company’s stock after acquiring an additional 18,778 shares during the quarter. Northern Trust Corp owned approximately 0.70% of Psychemedics worth $953,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Janney Montgomery Scott LLC raised its holdings in shares of Psychemedics by 14.2% during the second quarter. Janney Montgomery Scott LLC now owns 14,218 shares of the company’s stock worth $355,000 after purchasing an additional 1,767 shares during the period. JPMorgan Chase & Co. raised its holdings in shares of Psychemedics by 8.8% during the second quarter. JPMorgan Chase & Co. now owns 16,564 shares of the company’s stock worth $413,000 after purchasing an additional 1,345 shares during the period. LSV Asset Management raised its holdings in shares of Psychemedics by 193.4% during the second quarter. LSV Asset Management now owns 26,404 shares of the company’s stock worth $658,000 after purchasing an additional 17,404 shares during the period. Seizert Capital Partners LLC acquired a new stake in shares of Psychemedics during the second quarter worth $740,000. Finally, AJO LP acquired a new stake in shares of Psychemedics during the second quarter worth $832,000. Hedge funds and other institutional investors own 57.35% of the company’s stock.
Shares of Psychemedics Corp. (PMD) opened at $20.40 on Thursday. The company has a debt-to-equity ratio of 0.05, a current ratio of 2.72 and a quick ratio of 2.72. Psychemedics Corp. has a twelve month low of $13.81 and a twelve month high of $27.99. The firm has a market cap of $109.57, a PE ratio of 17.97 and a beta of 0.96.
The company also recently disclosed a quarterly dividend, which was paid on Friday, November 17th. Investors of record on Monday, November 6th were issued a $0.15 dividend. The ex-dividend date was Friday, November 3rd. This represents a $0.60 dividend on an annualized basis and a dividend yield of 2.94%. Psychemedics’s dividend payout ratio (DPR) is presently 54.05%.
Separately, BidaskClub raised shares of Psychemedics from a “sell” rating to a “hold” rating in a report on Saturday, November 4th.
COPYRIGHT VIOLATION WARNING: “Psychemedics Corp. (PMD) Shares Bought by Northern Trust Corp” was first posted by Ticker Report and is owned by of Ticker Report. If you are accessing this news story on another site, it was illegally copied and republished in violation of U.S. & international copyright & trademark legislation. The correct version of this news story can be read at https://www.tickerreport.com/banking-finance/3079073/psychemedics-corp-pmd-shares-bought-by-northern-trust-corp.html.
Psychemedics Corporation (Psychemedics) provides hair testing for drugs of abuse, utilizing a hair analysis method involving digestion of hair, enzyme immunoassay (EIA) technology and confirmation by mass spectrometry to analyze human hair to detect abused substances. The Company operates in drug testing services segment.
Want to see what other hedge funds are holding PMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Psychemedics Corp. (NASDAQ:PMD).
Receive News & Ratings for Psychemedics Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Psychemedics Corp. and related companies with MarketBeat.com's FREE daily email newsletter.